Src inhibitors in lung cancer: current status and future directions. - Wikidata - wikimedia - TriplyDB

Src inhibitors in lung cancer: current status and future directions.

Src inhibitors in lung cancer: current status and future directions.

http://www.wikidata.org/entity/Q37772683

about

ErbB2, EphrinB1, Src kinase and PTPN13 signaling complex regulates MAP kinase signaling in human cancers Wrangling phosphoproteomic data to elucidate cancer signaling pathways Regulation of SRC family kinases in human cancers An update on dual Src/Abl inhibitors.Nexus of signaling and endocytosis in oncogenesis driven by non-small cell lung cancer-associated epidermal growth factor receptor mutants.Src family kinases and paclitaxel sensitivity.miR-203 suppresses the proliferation and migration and promotes the apoptosis of lung cancer cells by targeting SRC.Control of asymmetric Hopfield networks and application to cancer attractors Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer Targeting invadopodia to block breast cancer metastasis Rhodomycin A, a novel Src-targeted compound, can suppress lung cancer cell progression via modulating Src-related pathways.The Effect of Chemoradiotherapy with SRC Tyrosine Kinase Inhibitor, PP2 and Temozolomide on Malignant Glioma Cells In Vitro and In Vivo MicroRNAs as the fine-tuners of Src oncogenic signalling.Aflatoxin B1 induces Src phosphorylation and stimulates lung cancer cell migration.MicroRNA-29b is involved in the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma.Melanoma Differentiation-associated Gene 7/IL-24 Exerts Cytotoxic Effects by Altering the Alternative Splicing of Bcl-x Pre-mRNA via the SRC/PKCδ Signaling Axis.HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms.The synergistic role of ATP-dependent drug efflux pump and focal adhesion signaling pathways in vinorelbine resistance in lung cancer.[Effects of Src on proliferation and invasion of lung cancer cells].YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting.Synthesis, biological evaluation and docking studies of new pyrrolo[2,3-d] pyrimidine derivatives as Src family-selective tyrosine kinase inhibitors.Targeting autophagy sensitises lung cancer cells to Src family kinase inhibitors.

P2860

Q24303562-30F1420F-8950-48A1-A4F3-78717AD6627A Q27323958-31BE4E40-E842-4F2E-AEDF-E783F14D08EC Q28243770-ACA75BD9-4739-423C-8B62-8464A594AD79 Q34270677-FE61167B-8959-499C-813C-EA8F4DBA4D1F Q34657670-C0C42B69-7AAF-4181-A378-ED9190867AA0 Q35214722-11084823-CE5C-4F3F-9DBB-D09B803C4BA3 Q35228579-7B943AC7-F75E-45A1-9DBF-E183825F4133 Q35234867-ABB8BA0F-70A6-47EB-9ABA-2897983D33E6 Q35587056-B46684F0-5E6E-45D4-AB0C-BEA4BD490A07 Q35640216-F8179F74-445F-4276-B8E2-353B0650F166 Q36413425-370A42D7-B313-48B1-A745-B9E4C814A469 Q36832243-7E61CA6A-0A9B-4F8B-AFD5-45BCDF1CA164 Q38415772-B225299F-2F17-4AD0-832B-75F33D160555 Q38893460-D3EF6E21-853A-47A8-B230-8ADD1B61CCBA Q39411400-E6A57317-919A-4DA2-89EA-30B52485FB95 Q42380691-9F6A41C5-FDF7-4936-9689-8D0CCB839C14 Q46666843-6AD6E7DD-5389-43A8-9536-BF06EE00A7CC Q47214772-647474F5-951E-43DF-8937-17EAE17A40E7 Q53287912-45AE7C46-44E9-45DE-9D08-505E4EF5429C Q53686708-746628AB-2512-4C69-9AE9-12F709859AA3 Q54485558-A351FAF8-9BC6-423A-897B-D963F2026B34 Q55280808-76217CB9-2F70-4A7B-84A2-77D5F107C54F

P2860

Src inhibitors in lung cancer: current status and future directions.

http://www.wikidata.org/entity/Q37772683

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Src inhibitors in lung cancer: current status and future directions.

@en

Src inhibitors in lung cancer: current status and future directions.

@nl

type

label

Src inhibitors in lung cancer: current status and future directions.

@en

Src inhibitors in lung cancer: current status and future directions.

@nl

prefLabel

Src inhibitors in lung cancer: current status and future directions.

@en

Src inhibitors in lung cancer: current status and future directions.

@nl

P1433

Q37772683-09CD2D33-FB20-44E8-9B8B-8AA75ACE1214

P1476

Q37772683-3CAC9F68-FF31-4A24-8508-6548EF3CAEEF

P2093

Q37772683-1F913DEA-D6A6-4590-83D6-3400496B553E

Q37772683-30580ED0-820C-46EE-8F8C-793B1FB42869

Q37772683-364FE7C8-BCEC-400A-BBD5-F51FFBFB415B

Q37772683-42C4C386-5FBB-4C6D-94EB-25556917E56F

P304

Q37772683-F6C952A2-A0ED-4E7F-9F83-BF8166AB237B

P31

Q37772683-6810BD18-6C7F-4C18-AA58-7F2F1E8955A3

P356

Q37772683-3C9BD974-C64A-4BD2-AC02-630D951E1019

P407

Q37772683-31C53CC7-C217-4113-85D4-D3048E1A811F

P433

Q37772683-2CE4C975-9144-42E9-AF18-BE66C95C7BB0

P478

Q37772683-6C55E152-E9E5-4B8A-A227-041135D4DF12

P577

Q37772683-80188F90-7047-48B4-B52F-35788F7D8007

P698

Q37772683-096E8198-66FE-4AE3-8FE2-6C758E130CA8

P356

P1433

Clinical Lung Cancer

P1476

Src inhibitors in lung cancer: current status and future directions.

@en

P2093

Eric B Haura

http://www.w3.org/2001/XMLSchema#string

Faye M Johnson

http://www.w3.org/2001/XMLSchema#string

Oliver Gautschi

http://www.w3.org/2001/XMLSchema#string

Sacha I Rothschild

http://www.w3.org/2001/XMLSchema#string

P304

238-242

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3816/CLC.2010.N.030

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20630825

http://www.w3.org/2001/XMLSchema#string